20 July 2025 - Australians with post-transplant cytomegalovirus, breast, bile duct and urothelial cancer now have access to new and expanded cheaper medicines under the PBS.
The PBS listing for Livtencity will be listed for the first time to treat illness caused by cytomegalovirus after a transplant.